Cabot CORP Schedule 13G passive stakes

A Schedule 13G filing reveals that American Century entities and Stowers Institute for Medical Research collectively hold a significant stake in Cabot Corporation.

Vanguard Capital Management has reported beneficial ownership of 5.22% of Cabot Corporation's common stock as of March 31, 2026.

Vanguard Portfolio Management has reported beneficial ownership of 3,175,315 shares, representing 6.08% of Cabot Corporation's common stock, as of March 31, 2026.

The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Cabot Corp following an internal realignment.

Wellington Management Group LLP and its affiliates have filed an amended Schedule 13G, reporting a passive beneficial ownership of 7.8% of Cabot Corporation's common stock as of March 31, 2025.